NCT04349865View on ClinicalTrials.gov

LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers

CompletedOBSERVATIONAL
Enrollment

211

Participants

Timeline

Start Date

May 22, 2018

Primary Completion Date

December 25, 2020

Study Completion Date

December 25, 2020

Conditions
Parkinson Disease
Trial Locations (1)

Unknown

Xuanwu Hospital of Capital Medical University, Beijing

All Listed Sponsors
collaborator

Michael J. Fox Foundation for Parkinson's Research

OTHER

lead

Xuanwu Hospital, Beijing

OTHER

NCT04349865 - LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers | Biotech Hunter | Biotech Hunter